Drug & medication recalls Moderate risk

Macleods Pharma Usa product recalled over manufacturing violations

Recall date
June 20, 2019
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Macleods Pharma Usa Inc recalls Losartan Potassium andHydrochlorothiazide Tablets 100 mg/25 mg 90 tablets, USP Rx Only, Manufactured for: Macleods Phar…
Recall number
D-1461-2019
FDA classification
Class II
Brand / firm
Macleods Pharma Usa Inc
Sold / distributed
Nationwide

Why it was recalled

CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Losartan Potassium andHydrochlorothiazide Tablets 100 mg/25 mg 90 tablets, USP Rx Only, Manufactured for: Macleods Pharma USA inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals, Ltd. Baddi, Himachal Pradesh, INDIA NDC 33342-052-10

Get recall alerts

Free email alert whenever Macleods Pharma Usa Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Macleods Pharma Usa Inc